Buscar
Mostrando ítems 11-20 de 994
Activation of PPAR alfa and PPAR beta/delta regulates Sertoli cell metabolism.
(Elsevier Ireland, 2014-01)
The purpose of this study was to evaluate the existence of a possible simultaneous regulation of fatty acid (FA) metabolism and lactate production by PPAR a and PPAR b/d activation in Sertoli cells (SC). SC cultures obtained ...
Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) gamma Activators and Pan-PPAR Partial Agonists
(Public Library Science, 2012-05-23)
Thiazolidinediones (TZDs) act through peroxisome proliferator activated receptor (PPAR) gamma to increase insulin sensitivity in type 2 diabetes (T2DM), but deleterious effects of these ligands mean that selective modulators ...
Agonistas de los PPAR como reguladores de anomalías fetales inducidas por la diabetes maternaPPAR agonists as regulators of fetal anomalies induced by maternal diabetes
(Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires, 2016)
Ppar alpha and ppar gamma regulate the nucleoside transporter hent1
(ACADEMIC PRESS INC ELSEVIER SCIENCE, 2012)
Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding
(PUBLIC LIBRARY SCIENCESAN FRANCISCO, 2012)
Peroxisome proliferator activated receptors (PPARs delta, alpha and gamma) are closely related transcription factors that exert distinct effects on fatty acid and glucose metabolism, cardiac disease, inflammatory response ...
Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function
(PUBLIC LIBRARY SCIENCE, 2011)
Background: Megalin is a large endocytic receptor with relevant functions during development and adult life. It is expressed at the apical surface of several epithelial cell types, including proximal tubule cells (PTCs) ...
Planejamento, síntese e avaliação farmacológica de novos compostos híbridos derivados de resveratrol e bezafibrato úteis ao tratamento da dislipidemia
(Universidade Estadual Paulista (Unesp), 2017-12-20)
A dislipidemia causada por hipertrigliceridemia e baixo HDL-C é um marcador de risco para a progressão da aterosclerose e doenças cardiovasculares. Os receptores PPARs são fatores de transcrição que controlam a expressão ...